Press release
United States Hepatorenal Syndrome Market Set for Rapid Growth Amid Rising Liver Disease Cases: Key Trends & Opportunities 2025 | Top key players - Mallinckrodt plc, Wellona Pharma, SiNi Pharma Pvt Ltd.
Credits Image: https://drnidoni.com
The Global Hepatorenal Syndrome Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Hepatorenal Syndrome Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/hepatorenal-syndrome-market?sz
The Hepatorenal Syndrome Market encompasses the development, production, and commercialization of therapies and diagnostic tools targeting hepatorenal syndrome-a serious kidney dysfunction occurring in patients with advanced liver disease. It includes pharmaceuticals, biologics, and supportive care solutions aimed at improving renal function, reducing complications, and enhancing survival rates among affected patients globally, driven by rising liver disease prevalence and increasing healthcare investments.
Recent Key Developments of United States (U.S):
September 2025: SeaStar Medical's Cytopheretic Device (SCD) was granted U.S. FDA Breakthrough Device Designation for the treatment of Hepatorenal Syndrome.
July-September 2025: Increased focus on the role of Terlipressin, the first FDA-approved treatment for Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI), with new data and educational programs highlighting its efficacy compared to older regimens.
August 2025: Continuation of regulatory trends prioritizing faster pathways (Fast-Track, Orphan Drug, Breakthrough Device) for novel pharmacologic agents and devices addressing unmet needs in severe conditions like HRS.
July 2025: Market analysts noted the growing impact of revised U.S. tariffs (implemented in spring/April 2025) on the pharmaceutical supply chain, potentially increasing costs for imported vasoactive therapies and essential renal replacement filters used in HRS treatment.
July-September 2025: Ongoing industry shift toward precision diagnostics and evidence-driven, algorithmic approaches to HRS management, emphasizing early hemodynamic stabilization and renal perfusion restoration as cornerstone strategies.
List of the Key Players in the Hepatorenal Syndrome Market:
Mallinckrodt plc
LEXICARE PHARMA PVT. LTD.
Wellona Pharma
Taj Pharmaceuticals Limited
SiNi Pharma Pvt Ltd
MANUS AKTTEVA BIOPHARMA LLP
New Medicon Pharma Lab
B JOSHI AGROCHEM PHARMA
Cygnus Healthcare Specialities Pvt. Ltd.
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=hepatorenal-syndrome-market
Segments Covered in the Hepatorenal Syndrome Market:
By Type: Type I, Type II.
By Treatment: Liver Transplantation, Terlipressin Infusion, Albumin Infusion, Hemodialysis, Vasoconstrictors, Antibiotic Therapy.
By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hepatorenal-syndrome-market?sz
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Hepatorenal Syndrome market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Hepatorenal Syndrome Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Hepatorenal Syndrome market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Hepatorenal Syndrome Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Hepatorenal Syndrome Market in 2025?
◆ What is the projected growth rate of the Hepatorenal Syndrome Market through 2033?
◆ Who are the key players in the Hepatorenal Syndrome Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Hepatorenal Syndrome Market Set for Rapid Growth Amid Rising Liver Disease Cases: Key Trends & Opportunities 2025 | Top key players - Mallinckrodt plc, Wellona Pharma, SiNi Pharma Pvt Ltd. here
News-ID: 4203586 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Tuberculosis Testing Market is estimated to reach US$ 2058.0 milli …
Market Size and Growth:
The Tuberculosis Testing Market size was valued at US$ 1,337.10 million in 2023 and is estimated to reach US$ 2058.0 million by 2030, growing at a CAGR of 6.0% during the forecast period (2024-2031). The Market is growing due to the rising prevalence of TB, increased government initiatives for early diagnosis, and advancements in rapid and accurate testing technologies.
Get a Free Sample PDF Of This Report (Get…
United States Paraganglioma Treatment Market Set to Surge: Innovative Therapies …
Market Overview:
The Global Paraganglioma Treatment Market is expected to grow at a CAGR of 6.42% during the forecast period (2024-2031). The Market is growing due to rising prevalence of paraganglioma, increased awareness for early diagnosis, and advancements in targeted therapies and minimally invasive treatments.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/paraganglioma-treatment-market?sz
The Paraganglioma Treatment Market encompasses therapies and interventions for managing paragangliomas, rare…
United States Antipeptic Ulcer Drugs Market is expected to reach US$ 6.26 Billio …
Market Size and Growth:
The Global Antipeptic Ulcer Drugs Market size reached US$ 4.56 Billion in 2023 with a rise of US$ 4.70 Billion in 2024 and is expected to reach US$ 6.26 Billion by 2033, growing at a CAGR of 3.2% during the forecast period 2025-2033. The Market is growing due to the rising prevalence of gastrointestinal disorders, increasing awareness about digestive health, and the adoption of advanced drug therapies…
United States Retinal Implants Market is estimated to reach US$ 118.17 million b …
Market Size and Growth:
The Global Retinal Implants Market size was valued at US$ 59.78 million in 2022 and is estimated to reach US$ 118.17 million by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031). The Market is growing due to increasing prevalence of retinal disorders and advancements in implant technology improving vision restoration.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email…
More Releases for Hepatorenal
Hepatorenal Syndrome Treatment: A Leading Driver Behind Rising Incidences Of Liv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hepatorenal Syndrome Treatment Industry Market Size Be by 2025?
The market for treating hepatorenal syndrome has witnessed a consistent growth in the past few years. The market size is projected to increase from $14.49 billion in 2024 to $15.17 billion in 2025, demonstrating a compound annual…
Hepatorenal Syndrome Market Trends, Growth Drivers, and Future Outlook
Hepatorenal syndrome (HRS) is a life-threatening complication of advanced liver disease, marked by rapid deterioration of kidney function in patients with cirrhosis or severe liver failure. The condition carries high mortality if untreated, making timely intervention and innovative therapeutic approaches critical. With the increasing prevalence of chronic liver diseases and rising awareness about advanced treatments, the hepatorenal syndrome market is poised for significant growth over the next decade.
Download Full PDF…
Rising Incidences Of Liver Damage And Cirrhosis Fueling Growth In The Hepatorena …
The Hepatorenal Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Hepatorenal Syndrome Treatment Market?
The Hepatorenal Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Hepatorenal Syndrome Pipeline Insights Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Hepatorenal Syndrome Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Hepatorenal Syndrome NDA approvals (if…
Hepatorenal Syndrome Market - Leading the Fight Against Hepatorenal Syndrome: So …
Newark, New Castle, USA: The "Hepatorenal Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatorenal Syndrome Market: https://www.growthplusreports.com/report/hepatorenal-syndrome-market/8838
This latest report researches the industry structure, sales, revenue,…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
